🔎 Trials Near Me

Gara Jalqabaatti › Kansaar Onnee Triple-Negative › Nevada

Qorannoo klinikaalii Kansaar Onnee Triple-Negative Nevada keessatti

Qorannoo 6 Kansaar Onnee Triple-Negative f Nevada keessatti hirmaatuu jiru.

Magaalota Nevada keessatti

Takkalaa qorannoo (Ingiliffa)

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

  • Comprehensive Cancer Centers of Nevada ( Site 0015), Las Vegas
  • Renown Regional Medical Center ( Site 0005), Reno
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06841354

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

  • Optum Care Cancer Center ( Site 9535), Las Vegas
  • Comprehensive Cancer Centers of Nevada - Peak ( Site 0047), Las Vegas
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06393374

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Optum Care Cancer Center ( Site 0050), Las Vegas
  • Renown Regional Medical Center ( Site 0041), Reno
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06966700

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Cancer Care Specialist of Reno, Reno
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 hanga 99 · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT07211178

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

  • Comprehensive Cancer Centers of Nevada, Las Vegas
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT07029399

A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors

  • Comprehensive Cancer Centers of Nevada, Las Vegas
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT05377996

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.